Cytiva, a global life sciences company, and Cellular Origins, a company working to advance scalable and cost-effective cell and gene therapy (CGT) manufacturing, have entered into a collaboration combining Cytiva’s automated Sefia platform with Cellular Origin’s automated robotic platform, Constellation. The companies aim to enable CGT manufacturers to scale up production to industrial levels without changing the process used during discovery phases or clinical trials. The two systems aim to ...